Abstract

BackgroundValidation of voltage-based scar delineation has been limited to small populations using mainly endocardial measurements. The aim of this study is to compare unipolar voltage amplitudes (UnipV) with scar on delayed enhancement cardiac magnetic resonance imaging (DE-CMR).MethodsHeart failure patients who underwent DE-CMR and electro-anatomic mapping were included. Thirty-three endocardial mapped patients and 27 epicardial mapped patients were investigated. UnipV were computed peak-to-peak. Electrograms were matched with scar extent of the corresponding DE-CMR segment using a 16-segment/slice model. Non-scar was defined as 0% scar, while scar was defined as 1–100% scar extent.ResultsUnipVs were moderately lower in scar than in non-scar (endocardial 7.1 [4.6–10.6] vs. 10.3 [7.4–14.2] mV; epicardial 6.7 [3.6–10.5] vs. 7.8 [4.2–12.3] mV; both p<0.001). The correlation between UnipV and scar extent was moderate for endocardial (R = -0.33, p<0.001), and poor for epicardial measurements (R = -0.07, p<0.001). Endocardial UnipV predicted segments with >25%, >50% and >75% scar extent with AUCs of 0.72, 0.73 and 0.76, respectively, while epicardial UnipV were poor scar predictors, independent of scar burden (AUC = 0.47–0.56). UnipV in non-scar varied widely between patients (p<0.001) and were lower in scar compared to non-scar in only 9/22 (41%) endocardial mapped patients and 4/19 (21%) epicardial mapped patients with scar.ConclusionUnipV are slightly lower in scar compared to non-scar. However, significant UnipV differences between and within patients and large overlap between non-scar and scar limits the reliability of accurate scar assessment, especially in epicardial measurements and in segments with less than 75% scar extent.

Highlights

  • The measurement of voltage amplitudes to distinguish scar tissue from viable myocardium is widely employed in invasive cardiology and electrophysiology including ablation therapy, targeted delivery of biological therapy, and cardiac resynchronization therapy (CRT).[1,2,3,4,5] Low voltage amplitudes are considered to be associated with scar, while high voltage amplitudes are regarded as viable myocardium.[2]Delayed enhancement cardiac magnetic resonance (DE-CMR) is currently the gold standard for myocardial scar delineation

  • Validation of intra-cardiac unipolar voltage amplitudes with the presence of myocardial scar assessed by cardiac magnetic resonance imaging

  • Significant unipolar voltage amplitudes (UnipV) differences between and within patients and large overlap between non-scar and scar limits the reliability of accurate scar assessment, especially in epicardial measurements and in segments with less than 75% scar extent

Read more

Summary

Introduction

Delayed enhancement cardiac magnetic resonance (DE-CMR) is currently the gold standard for myocardial scar delineation. Validation studies of voltage-based scar delineation conducted in ventricular tachycardia (VT) or HF patients have been limited by the small numbers of patients investigated, was focused on endocardial measurements, and do not provide data on the effectiveness at the individual level.[3, 9, 10]. Validation of voltage-based scar delineation has been limited to small populations using mainly endocardial measurements. The aim of this study is to compare unipolar voltage amplitudes (UnipV) with scar on delayed enhancement cardiac magnetic resonance imaging (DE-CMR)

Objectives
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call